Almoosa Health Company (TADAWUL:4018)

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Medical Services	917.51M	825.55M	735.45M	661.45M	577.23M
Medical Services Growth	11.14%	12.25%	11.19%	14.59%	11.08%
Rehabilitation	180.89M	118.54M	56.82M	-	-
Rehabilitation Growth	52.59%	108.64%	-	-	-
Pharmaceuticals	317.89M	258.24M	186.71M	154.59M	124.31M
Pharmaceuticals Growth	23.10%	38.31%	20.78%	24.36%	13.71%
Total	1.42B	1.20B	978.97M	816.04M	701.54M
Total Growth	17.79%	22.82%	19.97%	16.32%	11.54%

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Saudi Arabia	1.42B	1.20B	978.97M	816.04M	701.54M
Saudi Arabia Growth	17.79%	22.82%	19.97%	16.32%	11.54%
Total	1.42B	1.20B	978.97M	816.04M	701.54M
Total Growth	17.79%	22.82%	19.97%	16.32%	11.54%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error